-
Media Release /More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC alone in PSMAddition Deep PSA reduction higher in patients receiving Pluvicto…
-
Media Release /Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study1 40.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1…
-
Story /In a nationwide survey, more than 2,000 patients, caregivers, and clinicians told us what cancer care gets right, and where we can collaborate to improve.
-
Story /A year ago, we committed to investing $23 billion in America’s health over the next five years. Here’s a look at the impact we’ve made so far—plus a new initiative we’re launching in five cities to drive awareness and earlier detection of breast and prostate cancer.
-
Biography /
-
Biography /
-
Story /May is Stroke Awareness Month – a moment to pause and reflect on one of the leading causes of serious disability and death in the United States. Nearly 800,000 people in the US experience a stroke each year and every 40 seconds someone experiences one. Yet, despite how common stroke is, many people are still unaware of their risk – and what can be done to reduce it1.
Pagination
- ‹ Previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 88
- › Next page